Laurence Lejeune

1.2k total citations
16 papers, 1.0k citations indexed

About

Laurence Lejeune is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Laurence Lejeune has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Genetics. Recurrent topics in Laurence Lejeune's work include Virus-based gene therapy research (5 papers), Mesenchymal stem cell research (5 papers) and Angiogenesis and VEGF in Cancer (3 papers). Laurence Lejeune is often cited by papers focused on Virus-based gene therapy research (5 papers), Mesenchymal stem cell research (5 papers) and Angiogenesis and VEGF in Cancer (3 papers). Laurence Lejeune collaborates with scholars based in Canada, France and United States. Laurence Lejeune's co-authors include Jacques Galipeau, Nicoletta Eliopoulos, John Stagg, Sandra Pommey, Daniel Martineau, Kevin Lachapelle, A. Alkhaldi, Borhane Annabi, André Paquin and Mayya Mériane and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Laurence Lejeune

16 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurence Lejeune Canada 13 645 370 268 181 144 16 1.0k
Gill Adams United Kingdom 11 437 0.7× 284 0.8× 264 1.0× 165 0.9× 127 0.9× 13 926
Rosa María Pérez Yáñez Spain 14 818 1.3× 400 1.1× 391 1.5× 197 1.1× 205 1.4× 40 1.3k
Diana Buyaner United States 7 623 1.0× 261 0.7× 312 1.2× 102 0.6× 125 0.9× 7 844
Anthony S. Perry United States 10 610 0.9× 621 1.7× 385 1.4× 223 1.2× 194 1.3× 14 1.4k
Hadi Aslan Israel 9 938 1.5× 371 1.0× 490 1.8× 159 0.9× 218 1.5× 9 1.4k
Myoung Woo Lee South Korea 15 752 1.2× 377 1.0× 355 1.3× 164 0.9× 126 0.9× 28 1.1k
Hiroko Miyatake Japan 9 656 1.0× 371 1.0× 374 1.4× 145 0.8× 168 1.2× 13 1.1k
Chantal Lechanteur Belgium 21 802 1.2× 410 1.1× 515 1.9× 212 1.2× 188 1.3× 50 1.4k
Jason A. Mellad United Kingdom 8 611 0.9× 973 2.6× 300 1.1× 180 1.0× 94 0.7× 8 1.6k
Louisa Wirthlin United States 13 608 0.9× 621 1.7× 306 1.1× 343 1.9× 118 0.8× 23 1.6k

Countries citing papers authored by Laurence Lejeune

Since Specialization
Citations

This map shows the geographic impact of Laurence Lejeune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Lejeune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Lejeune more than expected).

Fields of papers citing papers by Laurence Lejeune

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Lejeune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Lejeune. The network helps show where Laurence Lejeune may publish in the future.

Co-authorship network of co-authors of Laurence Lejeune

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Lejeune. A scholar is included among the top collaborators of Laurence Lejeune based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Lejeune. Laurence Lejeune is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lejeune, Laurence, et al.. (2022). AFEST : quelles incidences sur la professionnalisation des formateurs ?. SPIRE - Sciences Po Institutional REpository. N° 231(2). 49–59. 2 indexed citations
2.
Martineau, Daniel, Moïra François, Laurence Lejeune, et al.. (2007). Plasminogen Kringle 5 blocks tumor progression by antiangiogenic and proinflammatory pathways. Molecular Cancer Therapeutics. 6(2). 441–449. 17 indexed citations
3.
Copland, Ian B., Laurence Lejeune, Nicoletta Eliopoulos, et al.. (2007). CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization. Experimental Hematology. 36(1). 93–103. 44 indexed citations
4.
Jaalouk, Diana E., Laurence Lejeune, Clément Couture, & Jacques Galipeau. (2006). A self-inactivating retrovector incorporating the IL-2 promoter for activation-induced transgene expression in genetically engineered T-cells. Virology Journal. 3(1). 97–97. 4 indexed citations
5.
Rafei, Moutih, Jian Wu, Borhane Annabi, et al.. (2006). A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex. Blood. 109(5). 2234–2242. 26 indexed citations
6.
7.
Nalbantoglu, Joséphine, Borhane Annabi, Laurence Lejeune, et al.. (2005). Plasminogen Kringle 5–Engineered Glioma Cells Block Migration of Tumor-Associated Macrophages and Suppress Tumor Vascularization and Progression. Cancer Research. 65(18). 8359–8365. 40 indexed citations
8.
Eliopoulos, Nicoletta, John Stagg, Laurence Lejeune, Sandra Pommey, & Jacques Galipeau. (2005). Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient mice. Blood. 106(13). 4057–4065. 445 indexed citations
9.
Eliopoulos, Nicoletta, Laurence Lejeune, Daniel Martineau, & Jacques Galipeau. (2004). Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells. Molecular Therapy. 10(4). 741–748. 27 indexed citations
10.
Stagg, John, Laurence Lejeune, André Paquin, & Jacques Galipeau. (2004). Marrow Stromal Cells for Interleukin-2 Delivery in Cancer Immunotherapy. Human Gene Therapy. 15(6). 597–608. 79 indexed citations
11.
Alkhaldi, A., Nicoletta Eliopoulos, Daniel Martineau, et al.. (2003). Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo. Gene Therapy. 10(8). 621–629. 167 indexed citations
12.
Boyer, Olivier, Gilles Marodon, José L. Cohen, et al.. (2002). Human CD4 Expression at the Late Single-Positive Stage of Thymic Development Supports T Cell Maturation and Peripheral Export in CD4-Deficient Mice. The Journal of Immunology. 169(8). 4347–4353. 1 indexed citations
13.
Cohen, José L., Marie‐Françoise Saron, Olivier Boyer, et al.. (2000). Preservation of Graft-versus-Infection Effects after Suicide Gene Therapy for Prevention of Graft-versus-Host Disease. Human Gene Therapy. 11(18). 2473–2481. 15 indexed citations
14.
Cohen, José L., Sébastien Lacroix‐Desmazes, Frédéric Charlotte, et al.. (1999). Immunological Defects after Suicide Gene Therapy of Experimental Graft-versus-Host Disease. Human Gene Therapy. 10(16). 2701–2707. 13 indexed citations
15.
Cohen, José L., Olivier Boyer, Benoı̂t L. Salomon, et al.. (1998). Fertile Homozygous Transgenic Mice Expressing a Functional Truncated Herpes Simplex Thymidine Kinase ΔTK Gene. Transgenic Research. 7(5). 321–330. 27 indexed citations
16.
Boyer, Olivier, José L. Cohen, D. Depétris, et al.. (1997). Position-dependent variegation of a CD4 minigene with targeted expression to mature CD4+ T cells. The Journal of Immunology. 159(7). 3383–3390. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gill Adams Breakdown of academic impact, for papers by Rosa María Pérez Yáñez Breakdown of academic impact, for papers by Diana Buyaner Breakdown of academic impact, for papers by Anthony S. Perry Breakdown of academic impact, for papers by Hadi Aslan Breakdown of academic impact, for papers by Myoung Woo Lee Breakdown of academic impact, for papers by Hiroko Miyatake Breakdown of academic impact, for papers by Chantal Lechanteur Breakdown of academic impact, for papers by Jason A. Mellad Breakdown of academic impact, for papers by Louisa Wirthlin
Rankless by CCL
2026